Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemia

Several novel therapeutics are poised to change the natural history of chronic lymphocytic leukaemia (CLL) and the increasing use of these therapies has highlighted limitations of traditional disease monitoring methods. Here we demonstrate that circulating tumour DNA (ctDNA) is readily detectable in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Paul, Hunter, Tane, Sinha, Devbarna, Ftouni, Sarah, Wallach, Elise, Jiang, Damian, Chan, Yih-Chih, Wong, Stephen Q., Silva, Maria Joao, Vedururu, Ravikiran, Doig, Kenneth, Lam, Enid, Arnau, Gisela Mir, Semple, Timothy, Wall, Meaghan, Zivanovic, Andjelija, Agarwal, Rishu, Petrone, Pasquale, Jones, Kate, Westerman, David, Blombery, Piers, Seymour, John F., Papenfuss, Anthony T., Dawson, Mark A., Tam, Constantine S., Dawson, Sarah-Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357854/
https://www.ncbi.nlm.nih.gov/pubmed/28303898
http://dx.doi.org/10.1038/ncomms14756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357854/
https://www.ncbi.nlm.nih.gov/pubmed/28303898
http://dx.doi.org/10.1038/ncomms14756

Ejemplares similares